Phibro Animal Health | PAHC - Cost Of Sales


Phibro Animal Health reported $240.42M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Align Technology USD 303.5M 60.47M Mar/2026
ANI Pharmaceuticals USD 114.5M 8.38M Mar/2026
Aurora Cannabis CAD 88.61M 30.53M Dec/2025
Bristol-Myers Squibb USD 3.86B 1.07B Mar/2026
Canopy Growth CAD 53.08M 8.3M Dec/2025
Corcept Therapeutics USD 2.88M 338K Mar/2026
Eli Lilly USD 3.58B 205M Mar/2026
Henry Schein USD 2.3B 145M Mar/2026
Idexx Laboratories USD 418.08M 14.38M Mar/2026
Knight Therapeutics CAD 82.22M 1.03M Dec/2025
Merck USD 2.94B 380M Mar/2026
Nektar Therapeutics USD 4.43M 5.3M Sep/2024
Pacira USD 50.74M 3.89M Mar/2026
Phibro Animal Health USD 240.42M 2.58M Dec/2025
Prestige Brands USD 140.76M 9.53M Mar/2026
Supernus Pharmaceuticals USD 49.04M 1.5M Mar/2026
Zoetis USD 672M 71M Mar/2026